#IDDF2022

Programme

Lecture Theatre 1B
2022-09-03
15:50-17:05
State Key Lab Meeting (1) - Molecular mechanisms of GI cancer
15:50
Genetic and epigenetic alterations in gastric cancer
16:10
Mettl3 as a therapeutic target in colorectal cancer
16:30
Dual function of MEN1 in modulating colon cancer tumor-microenvironment interactions
16:50
Q & A
Lecture Theatre 1B
2022-09-03
17:05-18:20
State Key Lab Meeting (2) - Microbiome/metabolites, gut-liver axis and liver diseases
17:05
Enterically derived HDL restrains liver injury through the portal vein
17:25
Intestine gene regulates NAFLD through gut-liver axis
17:45
Fecal mycobiome in NAFLD
18:05
Q & A
Lecture Theatre 1B
2022-09-04
09:00-10:30
State Key Lab Meeting (3) - Microbiome and host response
09:00
Microbiome in GI cancer
09:25
Genetic stability and individual specificity of the human gut microbiome
09:50
The role of inflammation in the development of Barrett’s esophagus and esophageal adenocarcinoma
10:15
Q & A
Lecture Theatre 1B
2022-09-04
11:00-12:30
State Key Lab Meeting (4) - Microbiome and cancer therapy
11:00
Microbiome and anti-cancer therapy
11:25
Enterococcus and cancer immunotherapy
11:50
Targeting microbiome for cancer prevention/treatment
12:15
Q & A
Lecture Theatre 1A
2022-09-04
14:30-16:00
COVID-19 and the GUT: lessons learnt
14:30
Gut microbiome and vaccine response
14:55
COVID-19 vaccine and immunosuppressants: chicken or egg?
15:20
Balancing your gut microbiome to fight COVID-19: what’s the evidence?
15:45
Q & A
State Key Lab Meeting (1) - Molecular mechanisms of GI cancer
Lecture Theatre 1B
2022-09-03
15:50
15:50
Genetic and epigenetic alterations in gastric cancer
16:10
Mettl3 as a therapeutic target in colorectal cancer
16:30
Dual function of MEN1 in modulating colon cancer tumor-microenvironment interactions
16:50
Q & A
State Key Lab Meeting (2) - Microbiome/metabolites, gut-liver axis and liver diseases
Lecture Theatre 1B
2022-09-03
17:05
17:05
Enterically derived HDL restrains liver injury through the portal vein
17:25
Intestine gene regulates NAFLD through gut-liver axis
17:45
Fecal mycobiome in NAFLD
18:05
Q & A
State Key Lab Meeting (3) - Microbiome and host response
Lecture Theatre 1B
2022-09-04
09:00
09:00
Microbiome in GI cancer
09:25
Genetic stability and individual specificity of the human gut microbiome
09:50
The role of inflammation in the development of Barrett’s esophagus and esophageal adenocarcinoma
10:15
Q & A
State Key Lab Meeting (4) - Microbiome and cancer therapy
Lecture Theatre 1B
2022-09-04
11:00
11:00
Microbiome and anti-cancer therapy
11:25
Enterococcus and cancer immunotherapy
11:50
Targeting microbiome for cancer prevention/treatment
12:15
Q & A
COVID-19 and the GUT: lessons learnt
Lecture Theatre 1A
2022-09-04
14:30
14:30
Gut microbiome and vaccine response
14:55
COVID-19 vaccine and immunosuppressants: chicken or egg?
15:20
Balancing your gut microbiome to fight COVID-19: what’s the evidence?
15:45
Q & A
About IDDF
The Organizer
The Organizing Committee
The Project Team
Venue
Follow Us
#IDDF2022
ATTENDING IDDF
Submit Abstracts
Submit Case Reports
Register
Accreditation
Programme
Speaker
PARTNERSHIP
Sponsors
Supporting Organization
MORE
Privacy Policy
Disclaimer
Contact Us
About IDDF
The Organizer
The Organizing Committee
The Project Team
Venue
ATTENDING IDDF
Submit Abstracts
Submit Case Reports
Register
Accreditation
Programme
Speaker
PARTNERSHIP
Sponsors
Supporting Organization
MORE
Privacy Policy
Disclaimer
Contact Us
Follow Us
#IDDF2022
SECRETARIAT
MIMS (Hong Kong) Limited

37/F., Citicorp Centre,
18 Whitfield Road,
Causeway Bay, Hong Kong
‍
E: info@iddforum.com
T: (852) 2116 4320
F: (852) 2559 6910
Organizers
PATRON:
Copyright © 2022. All Rights Reserved. Institute of Digestive Disease, The Chinese University of Hong Kong. Privacy | Disclaimer